Drug Discovery World
FEBRUARY 27, 2023
We will also see improved gene therapies and advanced CRISPR guide RNA design tools. It Over the next five years, there will be incredible developments in the next generation of RNA-based medicines such as mRNA vaccines and circular RNA, and RNA-targeting medicines, like small molecules and antisense oligonucleotides.
Drug Target Review
AUGUST 29, 2023
Progress has been made on raising awareness about the gender disparities and biases that exist within STEM fields through training programs and workshops to educate about unconscious biases and promoting diversity, but much work remains to be done. Before joining Flagship, Theonie received her Ph.D.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
NOVEMBER 15, 2022
As such, the synthesis of DNA oligonucleotides for routine molecular biology applications is often outsourced to service provider companies that operate DNA synthesisers to meet these demands. . A story-teller at heart, Ramanathan also delivers science communication workshops. . . . . .
Agency IQ
JANUARY 19, 2024
This process is more thoroughly covered in guidances on gene therapy and vaccine development, and in other guidelines, such as the ICH Q5B Guideline. a recombinant protein or gene therapy packaged via AAV virus) which has been produced by the cells, in addition to other debris such as the remaining media and the remnants of the cells.
Drug Discovery World
AUGUST 16, 2022
However, these social categories are rather arbitrary and don’t necessarily correspond to the underlying molecular biology of the patient, risking misguided clinical care. Instead, molecular markers are more accurate indicators of the patient’s associated risks. . People are beautifully different. References.
Codon
JUNE 26, 2023
Since the last Codon Digest, I’ve published: Reasons to Be Grateful for Biotechnology (with Avadhoot Jadhav) AAV Foundations (Part I) An overview of AAV-based gene therapies, how they get made, and where they go wrong. Nevertheless, phage therapy did have a stint in the U.S. I’ll post an update soon. coli in mice.
Codon
JUNE 26, 2023
Since the last Codon Digest, I’ve published: Reasons to Be Grateful for Biotechnology (with Avadhoot Jadhav) AAV Foundations (Part I) An overview of AAV-based gene therapies, how they get made, and where they go wrong. Nevertheless, phage therapy did have a stint in the U.S. I’ll post an update soon. coli in mice.
Expert insights. Personalized for you.
130 
Let's personalize your content